Codexis Inc (CDXS)
3.815
+0.32
(+9.31%)
USD |
NASDAQ |
Nov 05, 16:00
3.82
0.00 (0.00%)
After-Hours: 18:30
Codexis Profit Margin (Quarterly): -160.8% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -160.8% |
| June 30, 2024 | -285.2% |
| March 31, 2024 | -67.39% |
| December 31, 2023 | -27.08% |
| September 30, 2023 | -376.3% |
| June 30, 2023 | -54.04% |
| March 31, 2023 | -174.2% |
| December 31, 2022 | -41.49% |
| September 30, 2022 | -28.99% |
| June 30, 2022 | -6.87% |
| March 31, 2022 | -23.64% |
| December 31, 2021 | -41.59% |
| September 30, 2021 | 6.10% |
| June 30, 2021 | -16.76% |
| March 31, 2021 | -50.29% |
| December 31, 2020 | -18.64% |
| September 30, 2020 | -33.15% |
| June 30, 2020 | -42.39% |
| March 31, 2020 | -52.16% |
| December 31, 2019 | -3.40% |
| September 30, 2019 | 1.57% |
| June 30, 2019 | -52.82% |
| March 31, 2019 | -32.96% |
| December 31, 2018 | -2.87% |
| September 30, 2018 | -11.73% |
| Date | Value |
|---|---|
| June 30, 2018 | -27.59% |
| March 31, 2018 | -33.43% |
| December 31, 2017 | 4.47% |
| September 30, 2017 | -102.4% |
| June 30, 2017 | -60.69% |
| March 31, 2017 | -93.59% |
| December 31, 2016 | -52.76% |
| September 30, 2016 | 9.66% |
| June 30, 2016 | 13.99% |
| March 31, 2016 | -87.22% |
| December 31, 2015 | -17.72% |
| September 30, 2015 | 31.00% |
| June 30, 2015 | -89.07% |
| March 31, 2015 | -81.82% |
| December 31, 2014 | 2.43% |
| September 30, 2014 | -61.05% |
| June 30, 2014 | -129.1% |
| March 31, 2014 | -90.12% |
| December 31, 2013 | -103.0% |
| September 30, 2013 | -234.9% |
| June 30, 2013 | -180.7% |
| March 31, 2013 | -83.82% |
| December 31, 2012 | -196.4% |
| September 30, 2012 | -8.77% |
| June 30, 2012 | -24.09% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-376.3%
Minimum
Sep 2023
6.10%
Maximum
Sep 2021
-74.91%
Average
-41.54%
Median
Profit Margin (Quarterly) Benchmarks
| Rhythm Pharmaceuticals Inc | -110.9% |
| Allogene Therapeutics Inc | -- |
| Maravai LifeSciences Holdings Inc | -10.33% |
| Artiva Biotherapeutics Inc | -5.56K% |
| CEL-SCI Corp | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -79.15% |
| Return on Assets | -43.07% |
| Return on Invested Capital | -65.04% |
| Gross Profit Margin (Quarterly) | 66.36% |
| Operating Margin (Quarterly) | -129.0% |
| Return on Net Operating Assets | -105.9% |